Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Knop

Showing results (251-260 of 509) with videos related to

Pageof 51
Sort By:
Nutrients|February 26, 2025
Cholesin mRNA Expression in Human Intestinal, Liver, and Adipose TissuesHannah Gilliam-Vigh, Malte P Suppli, Sebastian M N Heimbürger, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 18, 2014
Decreased plasma chemerin levels in women with gestational diabetes mellitusK J Hare, L Bonde, J A Svare, et al.
BMJ Open|October 9, 2024
Semaglutide treatment for PRevention Of Toxicity in high-dosE Chemotherapy with autologous haematopoietic stem-cell Transplantation (PROTECT): study protocol for a randomised, double-blind, placebo-controlled, investigator-initiated studyMaria Ebbesen Sørum, Anne Ortved Gang, Dorte Maegaard Tholstrup, et al.
Diabetes, Obesity & Metabolism|August 9, 2017
The bile acid-sequestering resin sevelamer eliminates the acute GLP-1 stimulatory effect of endogenously released bile acids in patients with type 2 diabetesAndreas Brønden, Anders Albér, Ulrich Rohde, et al.
European Journal of Endocrinology|August 17, 2022
The glucagon receptor antagonist LY2409021 does not affect gastrointestinal-mediated glucose disposal or the incretin effect in individuals with and without type 2 diabetesSofie Hædersdal, Asger Lund, Elisabeth Nielsen-Hannerup, et al.
The Journal of Clinical Endocrinology and Metabolism|April 6, 2021
Response to Letter to the Editor from McKee and McGill: "Glycemic Control and Variability of Diabetes Secondary to Total Pancreatectomy Assessed by Continuous Glucose Monitoring"Caroline T B Juel, Thomas F Dejgaard, Carsten P Hansen, et al.
The Journal of Clinical Endocrinology and Metabolism|August 18, 2016
Higher Endogenous Glucose Production During OGTT vs Isoglycemic Intravenous Glucose InfusionAsger Lund, Jonatan I Bagger, Mikkel Christensen, et al.
Diabetologia|May 20, 2020
Pregnancy loss is associated with type 2 diabetes: a nationwide case-control studyPia Egerup, Anders P Mikkelsen, Astrid Marie Kolte, et al.
The Journal of Clinical Endocrinology and Metabolism|October 14, 2020
Glycemic Control and Variability of Diabetes Secondary to Total Pancreatectomy Assessed by Continuous Glucose MonitoringCaroline T B Juel, Thomas F Dejgaard, Carsten P Hansen, et al.
Diabetes Care|June 16, 2014
Glucose-lowering effects and low risk of hypoglycemia in patients with maturity-onset diabetes of the young when treated with a GLP-1 receptor agonist: a double-blind, randomized, crossover trialSigne H Østoft, Jonatan I Bagger, Torben Hansen, et al.
Pageof 51

Showing results (251-260 of 509) with videos related to

Sort By:
Pageof 51
Nutrients|February 26, 2025
Cholesin mRNA Expression in Human Intestinal, Liver, and Adipose TissuesHannah Gilliam-Vigh, Malte P Suppli, Sebastian M N Heimbürger, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 18, 2014
Decreased plasma chemerin levels in women with gestational diabetes mellitusK J Hare, L Bonde, J A Svare, et al.
BMJ Open|October 9, 2024
Semaglutide treatment for PRevention Of Toxicity in high-dosE Chemotherapy with autologous haematopoietic stem-cell Transplantation (PROTECT): study protocol for a randomised, double-blind, placebo-controlled, investigator-initiated studyMaria Ebbesen Sørum, Anne Ortved Gang, Dorte Maegaard Tholstrup, et al.
Diabetes, Obesity & Metabolism|August 9, 2017
The bile acid-sequestering resin sevelamer eliminates the acute GLP-1 stimulatory effect of endogenously released bile acids in patients with type 2 diabetesAndreas Brønden, Anders Albér, Ulrich Rohde, et al.
European Journal of Endocrinology|August 17, 2022
The glucagon receptor antagonist LY2409021 does not affect gastrointestinal-mediated glucose disposal or the incretin effect in individuals with and without type 2 diabetesSofie Hædersdal, Asger Lund, Elisabeth Nielsen-Hannerup, et al.
The Journal of Clinical Endocrinology and Metabolism|April 6, 2021
Response to Letter to the Editor from McKee and McGill: "Glycemic Control and Variability of Diabetes Secondary to Total Pancreatectomy Assessed by Continuous Glucose Monitoring"Caroline T B Juel, Thomas F Dejgaard, Carsten P Hansen, et al.
The Journal of Clinical Endocrinology and Metabolism|August 18, 2016
Higher Endogenous Glucose Production During OGTT vs Isoglycemic Intravenous Glucose InfusionAsger Lund, Jonatan I Bagger, Mikkel Christensen, et al.
Diabetologia|May 20, 2020
Pregnancy loss is associated with type 2 diabetes: a nationwide case-control studyPia Egerup, Anders P Mikkelsen, Astrid Marie Kolte, et al.
The Journal of Clinical Endocrinology and Metabolism|October 14, 2020
Glycemic Control and Variability of Diabetes Secondary to Total Pancreatectomy Assessed by Continuous Glucose MonitoringCaroline T B Juel, Thomas F Dejgaard, Carsten P Hansen, et al.
Diabetes Care|June 16, 2014
Glucose-lowering effects and low risk of hypoglycemia in patients with maturity-onset diabetes of the young when treated with a GLP-1 receptor agonist: a double-blind, randomized, crossover trialSigne H Østoft, Jonatan I Bagger, Torben Hansen, et al.
Pageof 51